Le Lézard
Classified in: Health, Business
Subjects: MAV, FVT

Media Advisory - Morneau Shepell experts to present insights on workplace health at health innovation conference


Inaugural conference to take place in Montreal on October 19

MONTREAL, Oct. 18, 2017 /CNW/ - More than 300 professionals in the health care field will gather in Montreal, Quebec to learn about best practices in the healthcare industry at the first edition of Expérience Innovation Santé (EXIS), a conference focused on health innovation, on October 19, 2017. EXIS will bring together health professionals and managers from across Canada to listen to relevant and insightful presentations on healthcare issues and trends.

Morneau Shepell's Dr. Bill Howatt, chief research and development officer, workforce productivity, and Dr. Tyler Amell, partner, are among eight speakers at the conference. Dr. Howatt will present on total health and resiliency, with a focus on chronic disease and what employers can do to help maintain employees' well-being. Dr. Amell will discuss innovative perspectives on workplace mental health and productivity, and how employers can improve the lives of their employees. 

Participants of the conference will also be able to experience exciting exhibits such as a mental health virtual reality booth and Ubisoft's O'Zen program, which helps users manage stress and improve concentration.

Media are invited to attend and are required to confirm their attendance through [email protected].

Event Details:

What:

Expérience Innovation Santé (EXIS), a conference focused on health innovation

When:

Thursday, October 19, 2017, from 8:00 a.m. to 4:30 p.m. (presentations begin at 9:00 a.m.)

Where:

TOHU, 2345 Jarry St. E., Montreal, Quebec, Map

Who:

The event will feature the following Morneau Shepell speakers:


  • Dr. Bill Howatt, Chief Research and Development Officer, Workforce Productivity
  • Dr. Tyler Amell, Partner

 

Media in attendance are encouraged to check in with the onsite media coordinator at the event: Benoit Lavigne, [email protected]

About Morneau Shepell

Morneau Shepell is the only human resources consulting and technology company that takes an integrated approach to employee assistance, health, benefits and retirement needs. The Company is the leading provider of employee and family assistance programs, the largest administrator of retirement and benefits plans and the largest provider of integrated absence management solutions in Canada. As a leader in strategic HR consulting and innovative pension design, the Company helps clients solve complex workforce problems and provides integrated productivity, health and retirement solutions.  Established in 1966, Morneau Shepell serves approximately 20,000 clients, ranging from small businesses to some of the largest corporations and associations. With more than 4,000 employees in offices across North America, Morneau Shepell provides services to organizations across Canada, in the United States and around the globe. Morneau Shepell is a publicly-traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit morneaushepell.com.

SOURCE Morneau Shepell Inc.


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: